These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 10321294

  • 1. [Screening for Chlamydia trachomatis infection: which group should be targeted and at what price?].
    van Vloten WA.
    Ned Tijdschr Geneeskd; 1999 Mar 27; 143(13):652-3. PubMed ID: 10321294
    [Abstract] [Full Text] [Related]

  • 2. [Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population of Amsterdam. Il Over 90% participation and almost 5% prevalence].
    van den Hoek JA, Mulder-Folkerts DK, Coutinho RA, Dukers NH, Buimer M, van Doornum GJ.
    Ned Tijdschr Geneeskd; 1999 Mar 27; 143(13):668-72. PubMed ID: 10321299
    [Abstract] [Full Text] [Related]

  • 3. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
    Postma MJ, Welte R, van den Hoek JA, van Doornum GJ, Coutinho RA, Jager JC.
    Ned Tijdschr Geneeskd; 1999 Mar 27; 143(13):677-81. PubMed ID: 10321301
    [Abstract] [Full Text] [Related]

  • 4. [Systematic home screening for Chlamydia trachomatis infections of asymptomatic men and women in family practice by means of mail-in urine samples].
    van Valkengoed IG, Boeke AJ, van den Brule AJ, Morré SA, Dekker JH, Meijer CJ, van Eijk JT.
    Ned Tijdschr Geneeskd; 1999 Mar 27; 143(13):672-6. PubMed ID: 10321300
    [Abstract] [Full Text] [Related]

  • 5. [Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population in Amsterdam. III. Cost-effectiveness analysis of screening women and the role of reinfection and partner treatment].
    Postma MJ, Welte R, van den Hoek JA, Jager JC, van Doornum GJ, Coutinho RA.
    Ned Tijdschr Geneeskd; 1999 Nov 20; 143(47):2383-5. PubMed ID: 10590778
    [Abstract] [Full Text] [Related]

  • 6. [Screening for Chlamydia trachomatis infection: which target group and at what price?].
    Postma MJ, van den Hoek JA.
    Ned Tijdschr Geneeskd; 1999 Jun 05; 143(23):1237-8. PubMed ID: 10428675
    [No Abstract] [Full Text] [Related]

  • 7. [The Dutch Health Council report on screening for Chlamydia: too reserved].
    Dekker JH.
    Ned Tijdschr Geneeskd; 2005 Apr 16; 149(16):850-2. PubMed ID: 15868986
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation and suggests targeted screening approaches: results from the first national population based study in the Netherlands.
    van Bergen J, Götz HM, Richardus JH, Hoebe CJ, Broer J, Coenen AJ, PILOT CT study group.
    Sex Transm Infect; 2005 Feb 16; 81(1):17-23. PubMed ID: 15681716
    [Abstract] [Full Text] [Related]

  • 9. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
    Ruitenberg EN.
    Ned Tijdschr Geneeskd; 1999 May 08; 143(19):1012. PubMed ID: 10368724
    [No Abstract] [Full Text] [Related]

  • 10. An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK.
    Norman JE, Wu O, Twaddle S, Macmillan S, McMillan L, Templeton A, McKenzie H, Noone A, Allardice G, Reid M.
    BJOG; 2004 Nov 08; 111(11):1261-8. PubMed ID: 15521872
    [Abstract] [Full Text] [Related]

  • 11. Managing genital chlamydia trachomatis infection in Scotland: targeted opportunistic testing or a screening programme?
    Clutterbuck DJ.
    Health Bull (Edinb); 2001 Nov 08; 59(6):396-404. PubMed ID: 12661390
    [Abstract] [Full Text] [Related]

  • 12. Opportunistic screening of young men for urogenital Chlamydia trachomatis infection in general practice.
    Andersen B, Eidner PO, Hagensen D, Lomborg S, Hoff G.
    Scand J Infect Dis; 2005 Nov 08; 37(1):35-9. PubMed ID: 15764188
    [Abstract] [Full Text] [Related]

  • 13. Is Europe ready for STD screening?
    Mårdh PA.
    Genitourin Med; 1997 Apr 08; 73(2):96-8. PubMed ID: 9215088
    [No Abstract] [Full Text] [Related]

  • 14. [Chlamydia trachomatis in pregnant women in the county of Vestsjaelland. Prevalence, prevention of perinatal transmission and cost-effectiveness of screening].
    Ottesen M, Sahl I, Herbstman MM, Friis HM, Philipsen T.
    Ugeskr Laeger; 1996 Feb 05; 158(6):756-8. PubMed ID: 8638313
    [Abstract] [Full Text] [Related]

  • 15. [Screening for asymptomatic Chlamydia trachomatis infection: cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
    Habets PC.
    Ned Tijdschr Geneeskd; 2001 Mar 10; 145(10):499-501. PubMed ID: 11268916
    [No Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness analysis of screening adolescent males for Chlamydia on admission to detention.
    Blake DR, Gaydos CA, Quinn TC.
    Sex Transm Dis; 2004 Feb 10; 31(2):85-95. PubMed ID: 14743071
    [Abstract] [Full Text] [Related]

  • 17. [Potentials of screening for Chlamydia trachomatis in Hungary: cost-benefit analysis].
    Nyári T, Mészáros G, Deák J, Nagy E, Kovács L.
    Orv Hetil; 2000 Jul 02; 141(27):1511-6. PubMed ID: 10943109
    [Abstract] [Full Text] [Related]

  • 18. A prediction rule for selective screening of Chlamydia trachomatis infection.
    Götz HM, van Bergen JE, Veldhuijzen IK, Broer J, Hoebe CJ, Steyerberg EW, Coenen AJ, de Groot F, Verhooren MJ, van Schaik DT, Richardus JH.
    Sex Transm Infect; 2005 Feb 02; 81(1):24-30. PubMed ID: 15681717
    [Abstract] [Full Text] [Related]

  • 19. [Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
    Postma MJ, Bakker A, Welte R, van Bergen JE, van den Hoek JA, de Jong-van den Berg LT, Jager JC.
    Ned Tijdschr Geneeskd; 2000 Dec 02; 144(49):2350-4. PubMed ID: 11129971
    [Abstract] [Full Text] [Related]

  • 20. [Chlamydia trachomatis infections--a time for action?].
    Mylonas I, Kirschner W, Weissenbacher T, Gingelmaier A, Weissenbacher ER, Friese K.
    Dtsch Med Wochenschr; 2007 May 25; 132(21):1170-6. PubMed ID: 17506013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.